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Abstract
Many patients in HIV care in Africa considered lost to follow up (LTFU) at one facility are
reportedly accessing care in another. The success of these unofficial transfers as measured
by time to re-entry at the new-facility, prevalence of treatment interruptions, speed of ART-
initiation, and overall continuity of care is not well characterized but may reveal opportunities
for improvement. We traced a random sample of LTFU HIV-infected patients in Zambia.
Among those found alive and reported in care at a new-facility, we reviewed records at the
receiving facility to verify transfer; and when verified, documented the transfer experience.
We used Kaplan-Meier methods to examine incidence of ART-initiation after transfer to new
clinic. We assessed demographic and clinical characteristics, official and cross-provincial
transfer for associations with HIV treatment re-engagement using Poisson regression mod-
els and associations between official-transfer and same-day ART initiation at the new-facil-
ity. Among 350 LTFU-patients, 178 (51%) were successfully verified through chart review at
the new-facility. 132 (74.2%) were female, 72 (40.4%) aged 25–35, and 51% were ever
recorded as previously being on ART. 110 patients (61.8%) were registered under new
ART-IDs and 97 (54.5%) received a new HIV test. 54% of those previously on ART-initiated
on the same-day. Using the same ART-ID was associated with same-day initiation com-
pared to those receiving a new ART-ID (p = 0.07). 80% (n = 91) of those ever on ART had
evidence of medication initiation at new clinic. Among these, initiation reached 66% (95%
CI: 56–75) by 30 days, 77.5% (95% CI: 68–86) by 90 days after new-facility presentation.
Many patients use new identifiers at new facilities, indicative of inefficiencies. Re-entry into
new facilities among the unofficial-transfer population is often delayed and timely treatment
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initiation is inconsistent, suggesting interruptions in treatment. Health systems innovations
to ensure smooth and safe transfers are needed to maintain quality HIV care.
Introduction
In the current era of universal treatment for all persons infected with HIV, poor retention in
care remains a substantial barrier to optimizing viral suppression [1]. Although routine pro-
grammatic data often indicate high level of lost to follow-up (LTFU)- particularly where sys-
tems are paper-based with no unique patient identifiers (IDs), several prior studies have
demonstrated that many patients considered LTFU at their original facility are in fact access-
ing care in another [2–9]. Though encouraging, current data only speak to whether a patient
has eventually transferred to a new facility or not. Unfortunately, current systems are poorly
equipped to accommodate the smooth transfer and tracking of patients from one facility to the
next due to the lack of unique patient IDs, multiple implementing partners and unified health
system records [10]. Thus, transfers may not be seamless, but it is not known to what extent
they undermine the significant clinical benefits of early and uninterrupted HIV treatment.
As HIV care is life-long and mobility is a normal part of livelihood and social practices,
improving our understanding of the experience and safety of transfers across facilities is
imperative for informing how to optimize receipt of patients previously on treatment else-
where [11]. Existing data suggests that the time between the last visit at the original facility and
the next visit at the receiving facility is often delayed: one recent study describing the patient
transfer experience among people living with HIV (PLHIV) in Kenya showed that treatment
gaps greater than 14 days were common [4]. This study also showed that rate to reengagement
differs by whether transfers are managed at the clinic level or ad-hoc by the patient (i.e., docu-
mented, official versus undocumented, unofficial transfers); for example, patients who left
with an official transfer letter reengaged in care six times faster than patients who did not. Fur-
ther evidence indicates that time to ART-initiation may vary by the distance from home to the
clinic where care is re-accessed [8]. These findings are suggestive of gaps in care associated
with patient transfer and differential rates of treatment initiation according to where patients
transfer and how and/or if they were managed appropriately. Further evidence on what hap-
pens to patients after they transfer, such as understanding the engagement process e.g. repeat
HIV testing, use of unique identifiers and CD4 testing is not well known.
To address these gaps, we undertook an assessment of patients who were LTFU according
to EMR records at their original facility and reported having transferred to a new facility after
being traced in the community in Zambia. We examined medical records at the receiving facil-
ity to verify patient-reported transfer and documented the transfer process including whether
patients registered under new names or ART IDs, whether the receiving facility appropriately
and rapidly staged and treated patients, and distances between original and new facility. We
characterized the incidence of ART-initiation between facilities and assessed whether the rate
of initiation was associated with transferring officially and/or across a province. Finally, we
evaluated characteristics associated with same-day ART-initiation at the transfer/new clinic.
Materials and methods
Patient population
The target population for this study are adults (�18 years) living with HIV infection in Zambia
who had transferred to a new facility. Our study population consisted of patients who were
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considered LTFU from HIV care (i.e., 90 days late to an appointment at the time of sampling)
at their original clinic based on EMR records, reported transferring to a new facility after being
actively traced in the field, and whose transfer was then verified at the new facility as part of
study activities for the Better Information for Health in Zambia cohort study [1]. The study
undertook a multistage sampling campaign and active tracing of a random sample of patients
LTFU in order to obtain regionally representative estimates of retention and mortality. We
selected using probabilities proportional to size a minimum of 2 to 10 facilities from each of 12
strata defined by facility type and province for a total of 32 government-operated HIV treat-
ment clinics in four provinces (Lusaka, Southern, Eastern, Western) that received technical
assistance support from the Centre for Infectious Disease Research in Zambia (CIDRZ), a
Zambian non-governmental organization. In each selected facility, we enumerated all adults
on ART who made a visit in the previous 24 months and identified lost to follow-up from this.
From patients lost to follow-up, we selected a simple random sample for tracing inverse pro-
portional to size.
Procedures and measurements
We hypothesise that some patients considered LTFU in one clinic are in fact seeking care else-
where. Among all patients who made at least one clinic visit between August 1, 2013 and July
31, 2015 to one of the study facilities, we actively traced in the community a random sample of
patients considered LTFU as of July 31, 2015 and administered a LTFU questionnaire that
included questions regarding whether they had transferred to a new facility, to which facility
they had transferred, the date of their first visit to the new facility, and their reasons for trans-
fer. Of note, patients who had a transfer to another facility with official documentation that
was documented in the EMR were not considered LTFU and were not included in our popula-
tion. We defined patients as “Previously on ART” if they had ever previously been initiated on
ART at their original clinic as per national ART guidelines. “Not on ART” or “Never yet initi-
ated on ART” was used to define those who had tested positive for HIV at their original clinic
but had never initiated ART based on the CD4 count threshold as per national ART guidelines
at the time [12]. Per our usage, someone who previously initiated on ART but then had a treat-
ment interruption was still considered as “Previously on ART”. Among those patients who did
report transferring their care to a new facility, tracers attempted to then verify the transfer by
going to the receiving facility and abstracting the patient health records through a combination
of EMR and paper chart review. Patients were matched using a combination of treatment
identifier numbers, name, and dates of birth at the receiving facility. Data collection included
information on whether there was official transfer documentation from the original clinics,
whether patient treatment identifiers were preserved (i.e. same ART ID used at the prior site
also used at receiving site), and the date of ART-initiation at the new clinic for those who had
previously initiated ART. We defined ART-initiation as a patient starting ART at a new receiv-
ing clinic regardless of them not having any treatment interruptions during transfer. Verifica-
tion was not attempted in facilities in provinces that were not supported by CIDRZ as study
sensitization was not possible nor in clinics under the Ministry of Defence. All other sociode-
mographic (sex, age), clinical (initial date of ART initiation, scheduled/ attended visit dates,
CD4 counts), and facility-level data (GPS coordinates) were obtained from the EMR.
Statistical analysis
We summarized patient and transfer characteristics using counts and proportions for categori-
cal variables, and medians and interquartile ranges (IQRs) for continuous data. To estimate
the transfer distances, we geocoded clinic locations using latitude and longitude measure,
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mapped transfers using QGIS 2.1.8 with standardized world geodetic system 1984 (Free Soft-
ware Foundation, Inc. Boston, MA 02110–1301 USA) using GADM (gadm.org University of
California, Davis U.S.A.) administrative boundary layers v2.8 (accessed November 2019), and
used the Vincenty formula to measure the distance in kilometres between clinic locations [13].
The map used is not copyrighted and allowed to be used freely.
To characterize time delays in transfers, we describe the percent of patients who had suc-
cessfully transferred over time since the date of their last scheduled pharmacy pickup date/ last
scheduled visit at the previous/original facility, which was used to approximate the last date
with which the patient was in possession of ART. For patients who were missing a scheduled
pharmacy pickup (n = 21), we used the mean time to next pharmacy pickup at their original
clinic to impute their next scheduled pickup. We fit a modified Poisson regression with robust
variances to assess the relationship between having no treatment interruption, defined as trans-
ferring to the new facility prior to being 14 days late to their previously scheduled pharmacy
pickup, with sociodemographic, clinical, and transfer characteristics. Covariates included in the
multivariable model were selected based on a priori hypotheses driven by previously identified
causal relationships using directed acyclic graphs to identify confounders (S1 Fig) [2, 4, 7, 14].
To assess re-engagement of patients after transferring to the new facility, we estimated the
cumulative incidence of ART-initiation at the new clinic using the Kaplan-Meier method
among patients who had previously been initiated on ART. Time zero was the date of the first
visit at the new clinic and patients were censored at the date of ART start (based on pharmacy
records) or administratively censored at the time of record review at the new facility (i.e., May
2016). We then fit a modified Poisson regression to assess the relationship between being initi-
ated on ART at the first visit after transfer with sociodemographic and transfer characteristics
based on a priori hypotheses of causal relationships.
Ethics
Ethical approval was obtained from the University of Zambia Biomedical Research Ethics
Committee (UNZABREC), University of Alabama at Birmingham (UAB) institutional review
boards (IRB) and Ministry of Health (MOH) prior to initiating study procedures. All partici-
pants provided written informed consent which was recorded on the consent form. All IRBs
approved this consent procedure.
Results
As described in the parent study, at the 32 selected sites, 104,966 patients made any visit
between August 1, 2013 and July 31, 2015 and 17,602 (17%) were LTFU [1]. We selected a ran-
dom sample of 2,892 lost patients (16% of 17,602 lost patients at 32 selected facilities) for inten-
sive tracing to ascertain current care status. Among the 2892 patients who were traced in the
field, updated information was found for 2,163 (75%), of whom 1,751 (81%) were alive.
Among those found alive, 456 (26%) had transferred to another facility but were originally
captured as LTFU in EMR at original facility (Fig 1). Among the 456 LTFU patients who were
traced in the field and reported transferring to a new facility 260 (57.0%) had previously initi-
ated ART, (65.1% female, median age 34 years [IQR 29–40], median CD4 272 cell/μL [IQR
139–445]), we attempted to verify 350 (77%) of these transfers and successfully verified 178
out of 350 (51%) (Table 1). Of these 178, 91 (51.1%) had initiated ART at their original facility
and the rest 87 (48.9%) were pre-ARTs and had not yet initiated ART at their original facility.
We did not attempt to verify reported transfers in 106 out of 456 (23%) patients due to the
patient transferring to a clinic that was managed by different partners and not affiliated with
CIDRZ and to which we do not have access to medical records. Among the patients in whom
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we attempted to verify their transfer, we were slightly more likely to verify transfers among
female patients, patients from rural clinics, and patients with a lower-middle basic education
level. In contrast, we were less likely to verify unofficial transfers in patients with lower CD4s,
urban populations, and patients with upper-basic/secondary education (Table 1).
Transfer characteristics
Among the total verified transfer population, the median gap between last scheduled pharmacy
pick up visit/ last scheduled clinic visit at the original facility and first clinic visit at the new
facility was 188 days (IQR: 44–446) (Table 2). 46 out of 178 (25.8%) had official transfer paper-
work from the original facility (i.e., official transfer documentation in new clinic paper record
but not captured in EMR at original facility). At the receiving facility, 68 (38.2%) patients used
the same ART ID, 97 (54.5%) received a new HIV test, and 57 (32.0%) received a new CD4 test
within 3 months of transferring. 49 (54.0%) of all 91 patients who had previously initiated
ART were initiated on ART the first day at the new facility (compared to 35 (40%) out of 87
patients who had not previously been on ART). Only 29 (65.9%) out of 44 patients who had
been on ART and had official transfer documentation were initiated on the same day. A
greater proportion of patients previously on ART were documented as official transfers (43%,
n = 39 out of 91) and used their previous ART number (n = 59, 65%) as compared to those not
previously on ART (n = 7, 8% and n = 9, 10%, out of 87 respectively) Table 2. Fig 2 shows
transfers based on geocoded clinic locations. 38 (21.3%) of all 178 verified transfers transferred
cross-provincially; the median distance between clinics was 27.1km (IQR 7.6, 76.0).
Time to transfer
Among patients previously initiated on ART, only 49 (53.8%) and 66 (72.5%) out of 91 had
transferred to the new facility by 6 months and 12 months after their last scheduled appoint-
ment at their original facility, indicating that a majority of patients experienced a prolonged
gap in medications and were out of care, meaning they had not yet presented to the new clinic
(e.g. 42 (46.2%) and 25 (27.5%) out of 91 at 6 months and 12 months) despite eventually trans-
ferring to a new facility (Fig 3A). For patients never yet initiated on ART, 36 (41.4%) and 56
Fig 1. Study population flowchart. Transfers undocumented at original facility for patients previously on ART and those previously not initiated on ART (N = 456).
https://doi.org/10.1371/journal.pone.0241477.g001
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(64.4%) out of 87 had transferred to the new facility by 6 months and 12 months after their last
scheduled appointment at their original facility (Fig 3B). Only 6 (6.9%) of patients never yet
initiated on ART and 19 out of 91 (20.9%) of patients previously initiated on ART had trans-
ferred without experiencing a gap in their care (i.e., transferred prior to their next scheduled
appointment).
In multivariate Poisson regression, we observed those that had official transfer paperwork
had a lower risk (RR 0.79, 95% CI 0.63–0.98, p = 0.04) of experiencing a medication gap of
�14 days (i.e., no gap in care) (Table 3.).
Table 1. Patient characteristics of all transfers identified in person.









Sex Female 297 (65.1) 242 (69.1) 132 (74.2) 110 (64.0%) 0.039
Age category <25 69 (15.1) 60 (17.1) 29 (16.3) 31 (18.0%) 0.91
25-35y 179 (39.3) 137 (39.1) 72 (40.4) 65 (37.8%)
35-50y 169 (37.1) 125 (35.7) 64 (36.0) 61 (35.5%)
>50y 39 (8.6) 28 (8.0) 13 (7.3) 15 (8.7%)
Enrollment CD4 cell count category
cell/μL
<200 115 (25.2) 82 (23.4) 34 (19.1) 48 (27.9%) 0.36
200–350 88 (19.3) 58 (16.6) 29 (16.3) 29 (16.9%)
350–500 55 (12.1) 45 (12.9) 26 (14.6) 19 (11.0%)
>500 69 (15.1) 53 (15.1) 25 (14.0) 28 (16.3%)
Missing 129 (28.3) 112 (32.0) 64 (36.0) 48 (27.9%)
WHO Stage at care initiation 1 203 (44.5) 162 (46.3) 84 (47.2) 78 (45.3%) 0.60
2 80 (17.5) 66 (18.9) 38 (21.3) 28 (16.3%)
3 98 (21.5) 66 (18.9) 33 (18.5) 33 (19.2%)
4 18 (3.9) 13 (3.7) 5 (2.8) 8 (4.7%)
Missing 57 (12.5) 43 (12.3) 18 (10.1) 25 (14.5%)
Marital status Single 71 (15.6) 50 (14.3) 23 (12.9) 27 (15.7%) 0.26
Married 272 (59.6) 214 (61.1) 105 (59.0) 109 (63.4%)
Divorced 64 (14.0) 48 (13.7) 29 (16.3) 19 (11.0%)
Widowed 42 (9.2) 32 (9.1) 20 (11.2) 12 (7.0%)
Unknown 7 (1.5) 6 (1.7) 1 (0.6) 1 (0.6%)
Education level None 22 (4.8) 22 (6.3) 7 (3.9) 15 (8.7%) <0.001
Lower-mid basic 166 (36.4) 141 (40.3) 92 (51.7) 49 (28.5%)
Upper basic/
Secondary
207 (45.4) 154 (44.0) 65 (36.5) 89 (51.7%)
College/University 52 (11.4) 24 (6.9) 10 (5.6) 14 (8.1%)
Missing 9 (2.0) 9 (2.6) 4 (2.2) 5 (2.9%)
Disclosure status Yes 408 (89.5) 309 (88.3) 158 (88.8) 151 (87.8%) 0.45
Facility type Rural 104 (22.8) 90 (25.7) 59 (33.1) 31 (18.0%) 0.003
Urban 230 (50.4) 165 (47.1) 71 (39.9) 94 (54.7%)
Hospital 122 (26.8) 95 (27.1) 48 (27.0) 47 (27.3%)
Province Eastern 69 (15.1) 66 (18.9) 37 (20.8) 29 (16.9%) 0.006
Lusaka 168 (36.8) 99 (28.3) 41 (23.0) 58 (33.7%)
Southern 137 (30.0) 113 (32.3) 52 (29.2) 61 (35.5%)
Western 82 (18.0) 72 (20.6) 48 (27.0) 24 (14.0%)
Previously on ART Yes 260 (57.0) 191 (54.6) 91 (51.1) 100 (58.1%) 0.19
Median time to LTFU (IQR) 0.7 (0.0, 2.8) 0.7(0.0,2.7) 0.7 (0.0, 2.7) 0.7 (0.0, 2.7) 0.63
Values N (%) or Median (IQR), WHO; World Health Organisation, ART; Antiretroviral Therapy, LTFU; Lost to follow up.
https://doi.org/10.1371/journal.pone.0241477.t001
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Time to ART-initiation among patients previously on ART
Based on Kaplan-Meier estimates, 61.3% (95% CI 51.4–71.3%), 77.5% (68.3%-85.6%), and
79.9% (70.9–87.5%) of patients who had previously been on ART had been started on ART at
the new clinic by 14, 90, and 180 days after new clinic presentation. Only 55.6% (95% CI 45.7–
66.0) were initiated on ART on the day of transfer while 20.1% (95% CI) had not yet been initi-
ated on ART by 180 days after transfer despite previously having been on ART (Fig 4).
In multivariate Poisson regression to assess same-day ART-initiation, using the same ART
ID from the previous clinic (RR 1.83, 95% CI 1.8–3.12, p = 0.026) was associated with starting
ART on the same day among patients who had previously been on ART (Table 4).
Discussion
We found evidence of engagement in care at the receiving clinic for patients originally classi-
fied as LTFU, with over half of transfers we attempted to verify contacted in person and
Table 2. Transfer characteristics of those identified at receiving facility.
Study Population
All verified
transfers n = 178
ART Status Transfer Status
Previously initiated on
ART n = 91
Never yet initiated on






Province of origin clinic
Lusaka 41 (23.0) 19 (21) 22 (25) 0.87 7 (15.2) 34 (26.0) 0.31
Eastern 37 (20.8) 20 (22) 17 (20) 12 (26.1) 24 (18.3)
Western 48 (27) 26 (29) 26 (30) 11 (23.9) 36 (27.5)
Southern 52 (29.2) 26 (29) 22 (25) 16 (34.8) 37 (28.2)
Cross Provincial Transfer 38 (21.3) 23 (25%) 15 (17) 0.19 14 (30.4) 24 (18.3) 0.085
Median time to transfer
(days), (IQR)




between clinics km, (IQR)
27.1 (7.6, 76.0) 47.6 (17.8,151.0) 21.8 (3.0, 45.5) <0.001 58.0 (23.1,239.9) 23.3 (5.5, 57.5) 0.003
Type of Transfer
Hospital to Hospital 19 (10.7) 14 (15) 5 (6) 0.26 6 (13.0) 13 (9.9) 0.86
Hospital to Rural 14 (7.9) 5 (5) 9 (10) 5 (10.9) 9 (6.9)
Hospital to Urban 17 (9.6) 7 (8) 10 (11) 4 (8.7) 13 (9.9)
Rural to Hospital 17 (9.6) 8 (9) 9 (10) 2 (4.3) 15 (11.5)
Rural to Rural 28 (15.7) 14 (15) 14 (16) 6 (13.0) 22 (16.8)
Rural to Urban 8 (4.5) 4 (4) 4 (5) 2 (4.3) 6 (4.6)
Urban to Hospital 17 (9.6) 12 (13) 5 (6) 5 (10.9) 12 (9.2)
Urban to Rural 19 (10.7) 11 (12) 8 (9) 6 (13.0) 13 (9.9)
Urban to Urban 25 (14.0) 10 (11) 15 (17) 5 (10.9) 19 (14.5)
Unknown 14 (7.9) 6 (7) 8 (9) 5 (10.9) 9 (6.9)
Prior ART 91 (51.1) - - 39 (84.8) 52 (39.7) <0.001
Official transfer 46 (25.8) 39 (43) 7 (8) <0.001 - -
Same ART ID new site 68 (38.2) 59 (65) 9 (10) <0.001 41 (89.1) 27 (20.6) <0.001
Received new HIV test 97 (54.5) 27 (30) 70 (80) <0.001 2 (4.3) 95 (72.5) <0.001
New CD4 test cell/μL 57 (32.0) 24 (26) 33 (38) 0.099 11 (23.9) 45 (34.4) 0.19
Same day ART initiation 84 (47.2) 49 (54) 35 (40) 0.069 25 (54.3) 58 (44.3) 0.24
All numbers are in n (%) or Median (IQR). Values N (%) or Median (IQR), WHO; World Health Organisation, ART; Antiretroviral Therapy, LTFU; Lost to follow up.
https://doi.org/10.1371/journal.pone.0241477.t002
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verified as receiving care at an alternate facility. Our findings revealed evidence suggestive of
potential poor transfer management at original and receiving sites, substantial gaps between
treatment visits, and rates to ART initiation which varied by important transfer characteristics.
In this study, patients who transferred from their original clinic were either “official transfers”,
in which a letter from original to receiving clinic was provided, or unofficial transfers/ “silent
transfers”, whereby no formal transfer documentation process was followed [15]. Using this
definition and according to our original clinic assessment using the EMR, we originally identi-
fied all 91 patients previously on ART as unofficial transfers, however, upon data abstraction
Fig 2. Transfers across study provinces. Inter and intra provincial transfer of patients originally identified as silent
transfers.
https://doi.org/10.1371/journal.pone.0241477.g002
Fig 3. Transfer status among patients. A) Time to transfer from last visit at original clinic among patients previously on
ART. B) Time to transfer from last visit at original clinic among patients not previously on ART.
https://doi.org/10.1371/journal.pone.0241477.g003
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activities at the receiving clinic, we found that approximately 43% of the 91 had in fact trans-
ferred with an official letter: indicating misclassification of patient status in the EMR. Misclas-
sifications of patient status indicate issues with data quality at both original and receiving
facilities. Because at the time in Zambia, patient records were largely first documented on
paper and later entered electronically (i.e. “e-last”), a potential reason for this misclassification
could have been the result of delayed transfer of information from the paper record into the
electronic record.
Our transfer verification process demonstrated that- while patients transferring officially
experienced shorter average gaps in treatment between sites- most patients still experience a
prolonged treatment lapse, a similar finding to Hickey et al. [4]. Other important insights from
our verification process, which involved abstraction of pharmacy and clinical records at both
the previous clinic and the receiving clinic of transfer, revealed a median treatment gap of over
half a year for all transfers regardless of ART status. Such significant gaps in treatment due to
Table 3. Results of multivariate Poisson regression evaluating predictors of transferring within 14 days of next
scheduled appointment, all verified transfers (n = 178).
Medication gap of 14 days RR (95% Confidence Interval) P-value
Male sex 1.06 (0.92–1.22) 0.39
Age at last visit, per year increase 1.00 (0.99–1.01) 0.37
Officially transferred 0.79 (0.63–0.98) 0.04
Previously on art 0.87 (0.74–1.03) 0.11
Time to LTFU 1.00 (0.96–1.04) 0.93
Cross provincial transfer 1.05 (0.90–1.22) 0.48
https://doi.org/10.1371/journal.pone.0241477.t003
Fig 4. Kaplan-Meier estimates of ART-initiation at new site. Cumulative incidence of ART-initiation by 14, 90, and
180 days since transfer to new site (n = 91).
https://doi.org/10.1371/journal.pone.0241477.g004
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slow transition between sites are a cause for serious concern, as any relapse in treatment repre-
sents vulnerability to virologic rebound [16–18]. Overall, our findings from our verification
process illustrate the importance of not only considering patient outcomes once received at a
new facility, but rather their entire process of accessing and transitioning care from one facility
to the next. By examining this process and relevant patient outcomes, we were able to paint a
fuller picture of patient transfers hence strategies that address or expedite this transfer process
in a timely fashion, thereby avoiding treatment failure are needed. Thus, while official transfer
letters may expedite ART-initiation once patients have successfully re-engaged at a new clinic,
this finding indicates that transition of care across facilities remains a challenge [2–4, 7, 8, 19,
20].
Our verification assessment revealed other important administrative and clinical inefficien-
cies. For example, among the patients we were able to verify at transfer sites, we found that just
over half received a new HIV test and just under two thirds received a new ART ID. In the
often overcrowded and overburdened HIV care clinics both in Zambia and in SSA at large,
time spent with providers is perhaps one the most precious of the limited resources [21]. Par-
ticularly in light of the current health care worker shortage crisis in Africa [22, 23], such clini-
cal inefficiencies represent an important area of improvement. Further, as ART services
continue to expand with the adoption of universal test and treat [12] the availability of treat-
ment support could even further diminish with a bourgeoning population of patients to serve,
making efficiency an even more important priority.
We found evidence for factors associated with ART-initiation even after successful re-
engagement with care: among patients who ever initiated, some failed to begin ART even up
to 180 days since new clinic presentation. Distance of transfer, especially among those transfer-
ring across provinces, could be a potential factor inhibiting swift ART initiation through sub-
optimal patient confirmation/identification processes at the facility-level. Nevertheless, it was
encouraging to find that in our study population, over 55% of patients who transferred initi-
ated ART on the same day they presented at the receiving clinic. Our mixed-effects Poisson
regression model revealed that among patients previously on ART once at the new site, using
the same ART I.D from the previous clinic had 1.8 times the odds of same-day initiation com-
pared to those without an ART I.D. Based on our knowledge of patient transfers in Zambia,
some of this could be due to the current process where patients sometimes carry a box of their
drugs when they report to the new facility or having some form of paperwork therefore mak-
ing their transfer seamless. The fact that these patients were recorded as LTFU at their original
facility shows that smooth management of a formal transfer process is driven by patients. In
some facilities, it has been reported that patients sometimes collect drugs under false names
hence it’s common for some providers to treat patients as new HIV patients prior to ART start
Table 4. Multivariate Poisson regression to assess same-day ART-initiation.
Same day initiation IRR Std. Err. z P>|z| [95% Conf. Interval]
Male 0.93 0.18 -0.38 0.71 0.64 1.35
Age at last visit 0.98 0.11 -1.65 0.09 0.96 1.00
Official transfer
Yes 1.02 0.19 0.11 0.91 0.70 1.49
Used same ART id
Yes 1.83 0.49 2.23 0.02 1.07 3.11
Cross Provincial transfer 0.92 0.18 -0.39 0.69 0.62 1.38
Medication gap _ 14days 1.67 0.47 1.81 0.07 0.95 2.92
_cons 0.46 0.24 -1.47 0.14 0.16 1.29
https://doi.org/10.1371/journal.pone.0241477.t004
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and this is sometimes based on the behaviour/ stigma in their clinic catchment population
[24]. Therefore, there are important areas for improvement at the facility level such as better
communication with the receiving facility, better provider patient relationships and ensuring
complete records are transferred to prevent unnecessary delays in seeking care, but also ensur-
ing that the original facility records the transfer in the EMR.
We were unable to verify just under 50% of transfers perhaps because patients may have
registered to their new clinic under a falsified name or acted as a new patient and subsequently
registered under a new ART ID, perhaps to avoid being reprimanded by clinic staff, or due to
a desire to maintain a level of anonymity [2, 4, 8, 24, 25]. Transitioning to an alternate site sim-
ilar to their original clinic with regard to clinic type (e.g. rural to rural) suggests a clinic shop-
ping phenomenon whereby patients elect to seek care at other facilities within their
community, something which has also been reported by others for within province transfers
[2, 9]. To mitigate the challenges of patient mobility, strategies that allow for use of unique
patient identifiers would be beneficial to managing ART programs and accurately accounting
for retention. Such strategies could include having a standard unique patient identifier at the
level of the national health system. Addressing the challenges of patient mobility may require
national adoption of mandatory issuance of a national registration numbers at birth [26]. This
number can then serve as a unique patient identifier for the entire health system and can be
used as a primary key for data linkages between facilities and various government registries
and programs [3]. For example, in quantifying the reasons for these verification failures,
we found that the majority were due to inability to find the patient by name, ART ID, or a
combination of the two in paper and/or electronic records at the receiving clinic. The reasons
for these failures could be due to a lack of organization at new sites, whereby paper files were
missing and/or not available–a common occurrence in HIV care clinics in Zambia [27]. It
could also be that patients did indeed access care at the indicated transfer facility, but poor
case management at the receiving site led to the generation of a new patient ART ID and there-
fore making him/her impossible to identify in our verification process. Improved data plat-
forms that ensure better management of electronic records would reduce the demand on
the health system in restaging and re-testing for blood–a suggestion also reported by Hickey
et al [4]. Integrating patient records into unique identifiers will improve the quality and conti-
nuity of care without having to repeat staging or ART initiation procedures–time and
resource-saving practices which are especially crucial given the healthcare worker shortage cri-
sis in SSA. Importantly, the gradual transition to “e-first” systems, whereby patient informa-
tion is first entered electronically, may be an important first step towards alleviating similar
issues related to lack of information sharing across facilities and/or delayed data entry in the
future.
With the adoption of universal test and treat [12], it is possible that treatment support
could even further diminish over time with increasing clinic size. Patient services may focus
more on treatment initiation with less focus on LTFU and patients that transfer [14, 28]. How-
ever, our findings instead demonstrate the importance of this “silent transfer” group to the
ultimate success of ‘90-90-90’: it is imperative to continue to describe the entire patient transfer
experience across clinics, understand the challenges they face, and explore options for
improvement. To our knowledge, only one other study has reported on the time to reengage-
ment in care following a silent transfer [4], and the other on the time to reengagement follow-
ing official transfers in low resource settings [11]. Ours is the first study that assessed transfer
characteristics cross-provincially and within province. Other study strengths include our
enhanced and intensive patient tracing approach, which encompassed verification of transfers
at the indicated transfer facility across four provinces in Zambia. We maintain that, while
demanding, undertaking this approach led to a better overall understanding of the patient
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transfer experience. Future research implementing this method in other contexts may reveal
additional opportunities for improvement.
Conclusions
Given that we found that patients originally considered LTFU in the original facility had trans-
ferred to a new facility and were accessing care, platforms that are able to uniquely identify
patients, allowing for better coordination and easy transition of patients from one facility to
another, as well as policies/procedures that are more flexible to patient clinic transfer are lack-
ing and/or require much improvement in the current context of HIV care in Zambia. Further
research that explores whether patients we were unable to verify at a new facility may have
indeed returned to care at original facility is required.
We speculate that improved facilitation of patient transfers will be imperative for preserving
the positive impact of ART for PLHIV and for the larger population as a whole. A nationally
comprehensive database and unique identifiers linking patient records over multiple years can
provide a more complete dataset than those available to researchers and planners. For exam-
ple, use of unique identifiers would avoid double counting the number of patients who have
been tested/ treated and improve follow-up with patients referred to other services such as
ART or even truly LTFU patients. Until now, and largely due to the success of ART programs,
insufficient attention has been given to the establishment of necessary linkages and integration
of HIV care within the broader health system; however, our findings indicate that this is an
important area of focus as we move towards reaching ‘90-90-90’ and ending the HIV epidemic.
Strategies that encourage patients to be more involved in discussions with health care workers
about their care may reduce unnecessary transfers due to poor staff attitude which leads to dis-
engagement and transfer to other facilities [7, 24, 29].
Limitations
In this study, we were limited to only one verification visit of transfers at the receiving facility,
hence further follow up with unverified transfers to understand why our verification was unsuc-
cessful would be necessary in order to ascertain if there were any reasons for disengagement. It is
possible that the unverified population may not have given us accurate information on the facility
they transferred to perhaps due to their experience of being reprimanded for delayed return to
care [24]. Additionally, further follow-up in our verified transfer population could reveal impor-
tant lessons regarding potential long-term impacts associated with clinic transfer- but was not
possible in the present study. Although we collected the distance between original and new facility,
our study could be further strengthened by a detailed description of the distance from their home.
In addition, we could have collected data about patients already on a particular ART regimen
being restarted on a different regimen when they present to a new clinic.
Third, our relatively small sample size precluded from further stratification to assess for less
prominent associations. Finally, it may be that the unverified patients never transferred to a
new facility but reported to the tracer to have done so due to social desirability bias. While our
failure to confirm patient transfer at the receiving site could have been due to any one or com-
bination of these reasons, our inability to verify a large proportion (~ 50%) of these patients at
all, even after undertaking exhaustive tracing efforts, highlights an important lesson. Our
study described transfers among those who accessed care, but the self-reported transfers of
those who did not access care is not represented; thus, the transfers within our study popula-
tion—whether provincial or cross provincial is likely higher than we found through our trac-
ing activities. Lastly, our sample size is not representative of all transfers but only those that
were not in EMR at original facility.
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Supporting information
S1 Fig. Direct acyclic graph. Direct acyclic graph to identify confounders of ART initiation
after presentation at a new site.
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